Bicalutamide |
Casodex |
Image:Bicalutamide.png Bicalutamide Systematic (IUPAC) name N-[4-cyano-3-(trifluoromethyl)phenyl]- 3-(4-fluorophenyl)sulfonyl-2- hydroxy-2-methyl- propanamide Identifiers CAS number 90357-06-5 ATC code L02BB03 PubChem 56069 DrugBank APRD00042 Chemical data Formula C18H14F4N2O4S Mol. weight 430.374 g/mol Pharmacokinetic data Bioavailability ? Protein binding 96% Metabolism ? Half life 5.9 days Excretion ? Therapeutic considerations ...
Wikipedia - [full article]
Resources
- Bicalutamide (Drug Digest)
- Casodex (Drug Digest)
Bicalutamide News Headlines
- Adjuvant Treatment With Bicalutamide In The N American Cohort Of The Early Prostate Cancer Trial Demonstrates No Benefit At 7.7 Years Follow-Up
MedicalNewsToday - Wed, 02 Aug 2006 06:00 EST
- The Early Prostate Cancer Trial And Adjuvant Anti-androgen Therapy: Still Defining The Role
MedicalNewsToday - Sat, 25 Feb 2006 10:00 EST

Not Signed In -

